Senior Food and Drug Administration officials knew about the monitoring of emails of scientists who had raised safety issues, The Wall Street Journal reported on 6 August.
Both commissioner Margaret Hamburg and the head of the FDA’s Centre for Devices and Radiological Health (CDRH), Jeffrey Shuren, knew the email accounts of five FDA scientists were being monitored starting in spring 2010, reports the paper, though the claim is they did not directly order the electronic spying.